{
    "title": "US FDA approves Pfizer's nasal spray for migraine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11844659/US-FDA-approves-Pfizers-pain-relief-nasal-spray-migraine.html",
    "date": "2023-03-10",
    "keywords": [
        "migraine",
        "drug",
        "pfizer",
        "khushi",
        "mandowara",
        "nasal",
        "spray",
        "zavzpret",
        "pill",
        "inc",
        "cgrp",
        "march",
        "food",
        "administration",
        "incs",
        "access",
        "painrelief",
        "option",
        "treatment",
        "company",
        "buyout",
        "year",
        "pipeline",
        "july",
        "price",
        "class",
        "zavegepant",
        "eli",
        "amgen",
        "peptide",
        "risk",
        "medication",
        "headache",
        "psychiatrist",
        "cleveland",
        "clinic",
        "estemalik",
        "edge",
        "category",
        "biohaven",
        "epipen",
        "action",
        "approval",
        "latestage",
        "study",
        "pain",
        "relief",
        "function",
        "research",
        "foundation",
        "noon",
        "trading",
        "reporting",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "anil",
        "dsilva",
        "vinay",
        "dwivedi",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}